Fieldpoint Private Securities’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$338K Sell
1,641
-408
-20% -$92K 0.1% 190
2022
Q1
$495K Buy
2,049
+234
+13% +$54.2K 0.1% 205
2021
Q4
$442K Buy
1,815
+5
+0.3% +$1.14K 0.09% 234
2021
Q3
$370K Sell
1,810
-31
-2% -$6.63K 0.08% 244
2021
Q2
$401K Sell
1,841
-11
-0.6% -$2.21K 0.09% 229
2021
Q1
$353K Sell
1,852
-335
-15% -$62.1K 0.08% 232
2020
Q4
$415K Buy
2,187
+213
+11% +$39.7K 0.09% 210
2020
Q3
$348K Sell
1,974
-118
-6% -$18.9K 0.1% 203
2020
Q2
$321K Sell
2,092
-1,605
-43% -$244K 0.11% 182
2020
Q1
$517K Sell
3,697
-2,842
-43% -$425K 0.2% 136
2019
Q4
$997K Buy
6,539
+1,934
+42% +$283K 0.29% 99
2019
Q3
$666K Sell
4,605
-538
-10% -$80.4K 0.24% 117
2019
Q2
$766K Buy
+5,143
New +$687K 0.24% 117

Other funds holding STE

Fieldpoint Private Securities's STE Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Steris (STE) stake by 20% in Q2 2022, selling an estimated $92K and leaving 1,641 shares worth $338K. The position accounts for 0.1% of the portfolio, ranked #190.

Fieldpoint Private Securities first reported a position in STE in Q2 2019 and has held it in 13 quarters since. The position peaked at $997K in Q4 2019. 665 funds tracked by Wall St. Rank hold STE as of Q2 2022.

  • Fieldpoint Private Securities held 1,641 shares of Steris worth $338K as of Q2 2022.
  • Fieldpoint Private Securities sold 408 Steris shares in Q2 2022, an estimated $92K.
  • Steris made up 0.1% of Fieldpoint Private Securities's portfolio in Q2 2022, its #190 holding.
  • Fieldpoint Private Securities first reported a position in Steris in Q2 2019 and has held it in 13 quarters since.
  • Fieldpoint Private Securities's Steris position peaked at $997K in Q4 2019.
  • 665 funds tracked by Wall St. Rank held Steris as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.